Forest Laboratories To Acquire Aptalis For $29 Billion In Cash | Latest News RSS feed

Forest Laboratories To Acquire Aptalis For $29 Billion In Cash - Latest News

Forest Labs (FRX) to Acquire Privately-Held Aptalis in $2.9B Deal

Forest Laboratories, Inc. (NYSE: FRX) announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal (GI) and Cystic Fibrosis comp... read more

Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Aptalis, a privately-held leading specialty pharmaceutical company, today announced that it has signed a definitive agreement to be acquired by Forest Laboratories ... read more

Forest Laboratories - Aptalis Deal Sparks More Enthusiasm

Acquisition Of Aptalis Forest Laboratories announced that it will acquire Aptalis for $2.9 billion in cash. Forest will acquire the privately ... EBITDA of the business rose by 29% to $315 million, va... read more

Looking for another news?

Forest Labs To Acquire Furiex Pharma A Deal Potentially Worth $1.46 Billion

... Officer and President of Forest Laboratories, Inc. Furiex is a drug development collaboration company, and Forest has agreed to acquire the company for $95 per share, or approximately $1.1 billion ... read more

Forest Labs to Buy Furiex Pharmaceuticals

The wave of deal-making in the drug industry continued on Monday when Forest Laboratories agreed to acquire Furiex Pharmaceuticals for up to ... or about $1.1 billion in cash, which is 19 percent abov... read more

The 6am London Cut

(Financial Times) The Panama Canal Authority has offered a cash advance of $100m ... (Financial Times) Forest Labs nears $3 billion deal for Aptalis: “Forest Laboratories Inc (is nearing an agreement ... read more

Forest Labs Soars on Aptalis Deal

Forest Laboratories, Inc. (NYSE:FRX) announced its intention to acquire U.S. based privately-held Aptalis for $2.9 billion in cash. The acquisition, which is expected to be immediately accretive, is s... read more

Deals of the day- Mergers and acquisitions

Activist hedge fund Elliott Management Corp offered to buy Riverbed Technology Inc for about $3.08 billion in cash, a move analysts ... Drugmaker Forest Laboratories Inc said it would buy specialty ph... read more

Forest Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript

Forest Laboratories (NYSE ... $751.8 million of product sales versus $1.1 billion last year, $65.8 million of contract revenue, which included $35.4 million from the Benicar agreement and $29.4 millio... read more

Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable

The rating actions follow the firm's announcement that it has entered a definitive agreement to acquire Allergan ... acquisition of Allergan to the close of its $25 billion purchase of Forest Laborato... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us